Fifth Third Bancorp’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.61K Buy
305
+15
+5% +$473 ﹤0.01% 2024
2025
Q1
$9.5K Buy
290
+44
+18% +$1.44K ﹤0.01% 2020
2024
Q4
$8.9K Sell
246
-26
-10% -$940 ﹤0.01% 2011
2024
Q3
$8.48K Buy
272
+7
+3% +$218 ﹤0.01% 2047
2024
Q2
$7.09K Buy
265
+28
+12% +$749 ﹤0.01% 2030
2024
Q1
$8.08K Buy
237
+12
+5% +$409 ﹤0.01% 1925
2023
Q4
$6.51K Buy
225
+131
+139% +$3.79K ﹤0.01% 2106
2023
Q3
$2.59K Sell
94
-63
-40% -$1.74K ﹤0.01% 2339
2023
Q2
$4.72K Buy
157
+95
+153% +$2.86K ﹤0.01% 2213
2023
Q1
$2.25K Hold
62
﹤0.01% 2541
2022
Q4
$2.21K Buy
62
+35
+130% +$1.25K ﹤0.01% 2416
2022
Q3
$1K Hold
27
﹤0.01% 2593
2022
Q2
$1K Sell
27
-244
-90% -$9.04K ﹤0.01% 2588
2022
Q1
$9K Sell
271
-6
-2% -$199 ﹤0.01% 2104
2021
Q4
$8K Buy
277
+203
+274% +$5.86K ﹤0.01% 2190
2021
Q3
$2K Buy
+74
New +$2K ﹤0.01% 2504
2021
Q1
Sell
-190
Closed -$5K 2497
2020
Q4
$5K Buy
+190
New +$5K ﹤0.01% 2117
2020
Q2
Sell
-112
Closed -$2K 2236
2020
Q1
$2K Hold
112
﹤0.01% 1994
2019
Q4
$3K Buy
+112
New +$3K ﹤0.01% 2028
2018
Q3
Sell
-10,738
Closed -$643K 2315
2018
Q2
$643K Sell
10,738
-2,701
-20% -$162K ﹤0.01% 621
2018
Q1
$616K Sell
13,439
-1,668
-11% -$76.5K ﹤0.01% 615
2017
Q4
$602K Buy
15,107
+3,521
+30% +$140K ﹤0.01% 637
2017
Q3
$463K Sell
11,586
-3,924
-25% -$157K ﹤0.01% 698
2017
Q2
$668K Sell
15,510
-4,638
-23% -$200K ﹤0.01% 615
2017
Q1
$631K Sell
20,148
-2,502
-11% -$78.4K ﹤0.01% 635
2016
Q4
$572K Sell
22,650
-5,136
-18% -$130K ﹤0.01% 683
2016
Q3
$687K Sell
27,786
-6,189
-18% -$153K 0.01% 640
2016
Q2
$692K Buy
33,975
+33,870
+32,257% +$690K 0.01% 632
2016
Q1
$2K Buy
105
+10
+11% +$190 ﹤0.01% 2181
2015
Q4
$1K Buy
95
+2
+2% +$21 ﹤0.01% 2648
2015
Q3
$1K Buy
93
+41
+79% +$441 ﹤0.01% 2782
2015
Q2
$1K Buy
+52
New +$1K ﹤0.01% 2761